ESOI Educational Webinars
dedicated to Oncologic Imaging

M. D'Anastasi, Msida/MT
D. Regge, Turin/IT
G. Zamboni, Verona/IT

Since 2015 ESOI has been proudly offering high quality webinars on various topics related to oncologic imaging. The live webinars have been very successful, well visited and have been attracting international participants from all over the world. In addition to the live broadcast, the recorded webinars are uploaded to the Member Area with a one month delay so they can be (re)viewed by active ESOI members at their own convenience.

The 2019 webinar programme will place great focus on multidisciplinarity and two interventional oncology webinars will be added to the monthly sessions.

ESOI webinars last approximately 60 minutes (45 min. presentation and 15 min. for discussion/questions).

The first two webinars of the year are open to anyone interested. Further webinars are open to active ESOI members only.

Sponsored by Bracco

Webinar Certificate 2019

The ESOI Webinar Certificate will be issued at the end of the calendar year.

In order to obtain the certificate, active ESOI full / allied sciences members must attend a minimum of 8 webinars in 2019.
ESOI resident members must attend the 2 dedicated Young Radiologists Webinars in addition to 7 other webinars, so a total of 9 webinars.
In addition to the attendance during the live webinars, the assessment tests following each individual webinar must be submitted. To qualify for the certificate, at least 70% of the submitted questions must be answered correctly.

Please note:
The assessment questions will only show after the live sessions and there will be no other possibility to submit your answers.
Furthermore, we do not recommend to follow the webinars in a group, as only the person registered and logged in to the respective webinar will be able to answer the questions at the end. 

We kindly ask for your understanding that currently ESOI Educational Webinars are not CME accredited.

ESOI Educational Webinars 2019


ESOI/EuSoMII Joint Multidisciplinary Webinar
Artificial intelligence in oncologic imaging: Current status and future directions

E. Neri, Pisa/IT (Radiologist)
A. Alberich Bayarri, Valencia/ES (Telecommunications Engineer)
August 28, 2019
18:00 CEST

Webinar overview
The webinar will cover the main aspects on image normalisation, segmentation and extraction of radiomics features through the use of artificial intelligence techniques such as convolutional neural networks for organ detection and lesion segmentation. The process for performing a comprehensive radiomics analysis will be presented.

Learning objectives
- To understand the steps of a radiomics analysis
- To learn how to use artificial intelligence techniques to optimize the oncologic image analysis pipline
- To learn the steps of imaging biomarkers extraction
- To understand the importance of clinical endpoints for oriented radiomics reseearch

About the speakers
Emanuele Neri, MD is the Chair of the 3rd Diagnostic Radiology Unit, at Pisa University Hospital. He is also the Chair of the Masters Courses in Interventional Radiology and Oncologic Imaging and Vice Chair at University of Pisa.
Prof. Neri is past chair of the e-Health and Informatics subcommittee of the European Society of Radiology (ESR), and past Chair of the CT dose repository subgroup of EuroSafe. He served in ESR also as chair of the Imaging Biobanks working group, and of the Computer Applications subcommittee. Prof. Neri is Chairman of the Research Committee and member of the Board of European Society of Oncologic Imaging (ESOI) and Past President of the European Society of Medical Imaging Informatics (EuSoMII). Since 2013 he is member of the Radiology Informatics Committee of the Radiological Society of North America (RSNA).
Prof. Neri spent most of his scientific / research carrier in the field of imaging informatics, gastrointestinal imaging and head and neck imaging.
The most recent activities of Prof. Neri have been focused on the development and validation of imaging biomarkers, imaging biobanks and artificial intelligence.

Angel Alberich-Bayarri, PhD is a telecommunications Engineer with specialisation in electronics and PhD in Biomedical Engineering (2010). In the professional aspect he is scientific-technical director of the Biomedical Imaging Research Group of the Polytechnics and University Hospital La Fe, as well as founder and director of the spin-off company QUIBIM (Quantitative Imaging Biomarkers in Medicine), dedicated to the advanced analysis of medical images.
In the research field, he is the author of more than 60 scientific articles in prestigious international journals and inventor of 3 patents. He is also the author of more than 80 communications to international congresses, editor of 2 international books and author of 15 book chapters.
He is an active member of several scientific societies, among which stands out his participation as a member of the Board of Directors of the European Society of Medical Imaging Informatics (EUSOMII) and member of the e-Health Committee of the European Society of Radiology.
Among many other awards, in 2013 he received the European Pro-Academy Prize award, which is awarded to the scientific leaders of exemplary groups in science and academic life. In 2014 he was recognized by the European Society of Radiology with the award for the best scientific contribution in the field of oncology.

This webinar is open to active ESOI and EuSoMII members.
Please note that ESOI reserves the right to contact the EuSoMII Office to check for valid membership.
In order to register please ensure your active membership and complete the online registration: Webinar registration


ESOI/ESSO/EUSOBI Joint Multidisciplinary Webinar
Breast cancer: A multidisciplinary approach to imaging in neoadjuvant treatment

M. Lobbes, Sittard-Geleen/NL (Radiologist)
M. L. Smidt, Maastricht/NL (Surgeon)
September 9, 2019
18:00 CEST

Webinar overview
Imaging of breast cancer patients treated with neoadjuvant chemotherapy influences treatment decision and impacts patient’s outcome. In this clinical decision-making process, imaging plays a pivotal role, with various modalities (such as(contrast-enhanced) mammography, tomosynthesis, ultrasound and breast MRI) being at the disposal of the radiologist. Every modality has its strengths and weaknesses in terms of response monitoring of patients treated with neoadjuvant chemotherapy. It is essential that all involved clinicians are aware of these, but also know how these findings impact clinical decision making. This joint ESOI/ESSO/EUSOBI webinar approaches imaging from a multidisciplinary view. Attendees will learn about multidisciplinary team management, the relevant questions from clinicians and how radiologists can answer these by applying different techniques. Short lectures will be followed by case-based discussions among the teachers and attendees, in this way simulating a multidisciplinary meeting.

About the speakers

Dr. Marc Lobbes is the director of the breast imaging center of the Zuyderland Medical Center in Sittard-Geleen, the Netherlands. He has an extensive expertise in all areas of breast imaging, including mammography, tomosynthesis, ultrasound, interventions and breast MRI, including breast PET-MRI. Dr. Lobbes was the first radiologist in the Netherlands to apply contrast-enhanced mammography and has published multiple scientific publications on this topic, including several book chapters. His primary research focus is the application of machine learning in (breast) oncologic imaging, the clinical implementation of contrast-enhanced mammography and MR imaging of the breast and axilla (the latter in close collaboration with dr. Smidt). He is an active member of the Dutch Society of Breast Imaging, member of the scientific counsel of the Dutch Expert Center for Screening and educational board member of the European Society of Breast Imaging (EUSOBI).

Dr. Marjolein Smidt is associate professor surgical oncology at the Maastricht University Medical Centre in Maastricht, The Netherlands, where she co-chairs the Comprehensive Cancer Centre as well as presides GROW research school’s program 2 concerning clinical research. Amongst others, she is a member of the SSO and ESSO scientific program committee and board member of UEMS on breast cancer surgery, which organizes the European exams on breast cancer surgery.
She has extensive knowledge in the field of breast cancer surgery and research.
“During the last decades, breast cancer survival increased impressively as a consequence of early detection and extensive adjuvant treatment. Consequently attention shifted from only aiming survival to a combined and patient-tailored endpoint including both survival as well as reducing morbidity, thereby improving quality of life. As a result of this attention shift, the question arose: “Which treatment is no longer necessary anymore?”. From a surgical point of view this means "Less invasive, equally safe” thereby limiting morbidity resulting from the extensive adjuvant treatment universal package deals. Concerning axillary treatment, the ultimate goal is axillary treatment which is equally safe in outcome (DFS) though less invasive and consequently results in less lifelong morbidity. This research line started with noninvasive nodal staging study with contrast enhanced MRI. This MRI offered comparable axillary knowledge as the sentinel biopsy, however without operating. Since the contrast was taken off-market, our search for a noninvasive imaging continued. Currently we are exploring the potential of PET-MR for nodal (re)staging in breast cancer patients.

This webinar is open to active ESOI, ESSO and EUSOBI members.
Please note that ESOI reserves the right to contact the ESSO and EUSOBI Offices to check for valid membership when you register via the below link.
Besides, due to the limit of 500 parallel attendees during the live session registrations will be accepted on a first come first serve basis.
In order to register please ensure your active membership with at least one society and complete the online registration: Webinar registration

ESOI/ESHI-MT Joint Webinar
Clinical relevance of PSMA PET/CT: An overview and update

C. Cyran, Munich/DE
September 18, 2019
17:00 CEST

ESOI/ESNR Joint Webinar
Assessing response to therapy of brain tumours 

P. M. Sundgren, Lund/SE
September 25, 2019
18:00 CEST

ESOI Interventional Oncology Webinar
Interventional oncological treatment of lung nodules/lung cancer 

J. Palussière, Bordeaux/FR
October 10, 2019
18:00 CEST

ESOI Multidisciplinary Webinar
Pancreatic cancer: A multidisciplinary approach to imaging

G. Zamboni, Verona/IT (Radiologist)
G. Marchegiani, Verona/IT (Surgeon)
October 30, 2019
18:00 CET

ESOI Young Radiologists' Webinar
New paradigms in scientific publishing

M. F. Reiser, Munich/DE
November 20, 2019
18:00 CET

ESOI Multidisciplinary Webinar
Correlation of radiological images with surgical findings in ovarian peritoneal disease

L. Fournier, Paris/FR (Radiologist)
A. S. Bats, Paris/FR (Surgeon)
December 18, 2019
18:00 CET

As an active ESOI member you benefit from access to the recordings of our past webinars!

Past Webinars 2019

Multidisciplinary Webinar
Prostate cancer: a multidisciplinary approach to imaging
H. P. Schlemmer, Heidelberg/DE (Radiologist)
J. P. Radtke, Heidelberg/DE (Urologist)

Immune therapy: Response assessment and toxicity
D. Regge, Turin/IT

Small bowel tumours
M. Gollub, New York/US

ESOI Interventional Oncology Webinar
Interventional oncological options for RCC
M. Krokidis, Cambridge/UK

ESOI/ESSO/ESTRO Joint Multidisciplinary Webinar
Rectal cancer: A multidisciplinary approach to imaging
R. Beets-Tan, Amsterdam/NL (Radiologist)
N. Figueiredo, Lisbon/PT (Surgeon)
R. Glynne-Jones, Northwood/UK (Radiation Oncologist)

ESOI/ESSR Joint Young Radiologists' Webinar
Imaging and response assessment of multiple myeloma
A. Baur-Melnyk, Munich/DE


Past Webinars 2018

Multidisciplinary Webinar
1. Rectal Cancer: a multidisciplinary approach to imaging
R. Beets-Tan, Amsterdam/NL, radiologist
G. Beets, Amsterdam/NL, surgeon
B. van Triest, Amsterdam/NL, radiation oncologist

2. Cross-sectional imaging of renal tumours
R. Pozzi Mucelli, Verona/IT

Young Radiologists Webinar
3. Structured reporting in prostate cancer
D. Regge, Turin/IT

4. Imaging of testicular tumours
M. Bertolotto, Trieste/IT

Multidisciplinary Webinar
5. Preoperative local staging of breast cancer: tailoring the surgical treatment
J. Camps Herrero, Alzira/ES, radiologist
R. Ponzone, Turin/IT, surgeon

Young Radiologists Webinar
6. Response evaluation in oncology: RECIST 1.1
M. D'Anastasi, Msida/MT

7. Algorithmic approach to the female pelvic mass
E. Sala, Cambridge/UK

8. Molecular and hybrid imaging in prostate cancer
G. Cook, London/UK

ESOI/ESSO Multidisciplinary Webinar
Rectal cancer: a multidisciplinary approach to imaging
G. Beets, Amsterdam/NL
R. Beets-Tan, Amsterdam/NL
B. van Triest, Amsterdam/NL

9. Diagnosis and staging of oesophageal and gastric cancer
M. Laniado, Dresden/DE

10. Neuroendocrine tumours - radionuclide imaging and therapy  
H. Ilhan, Munich/DE

Young Radiologists Webinar
11. Structured reporting in rectal cancer
M. Maas, Amsterdam/NL

12. Imaging after treatment of lung cancer
J. Dinkel, Munich/DE

Interventional Oncology Webinar 1
Multidisciplinary management of CRC liver metastases  
Th. Helmberger, Munich/DE

13. Lung cancer screening - what did we learn so far?
C. Schaefer-Prokop, Amersfoort/NL

14. Assessment of the treatment response of bone lesions in cancer patients: pearls and pitfalls
F. Lecouvet, Brussels/BE

15. Imaging and response assessment of gastrointestinal stromal tumours
A. Laghi, Rome/IT

Past Webinars 2017 
1. Imaging of CNS tumours
P. Parizel, Antwerp/BE
2. Imaging and differential diagnosis of orbital tumours
U. Mueller-Lisse, Munich/DE

3. Imaging of lymphomas
M. Mayerhöfer, Vienna/AT

4. Imaging spectrum of primary and secondary mesenteric neoplasms
S. Nougaret, Montpellier/FR

5. Imaging of the treated pelvis: Pearls and pitfalls
E. Sala, New York/US

6. MR imaging of malignant diseases of the uterus
Y. Lakhman, New York/US

Young Radiologists Webinar
7. Practical advice in preparing successful scientific manuscripts
M. Reiser, Munich/DE

8. Imaging of recurrent prostate cancer
H. Vargas, New York/US

9. Bone metastases, how should we approach them with imaging?
T. Bäuerle, Erlangen/DE

10. PET-MRI in oncologic imaging - where do we stand?
V. Goh, London/UK

11. When to call a lesion an HCC?
G. Brancatelli, Palermo/IT

12. Current evidence for minimally invasive treatments in HCC
J. Ricke, Munich/DE

Young Radiologists Webinar
13. Diagnostic test studies: how I do it
M. Maas, Amsterdam/NL

14. Paediatric abdominal tumours
C. Granata, Genoa/IT

Past Webinars 2016

1. Staging of Rectal Cancer with MRI
R. Beets-Tan, Amsterdam/NL

2. Contrast-enhanced ultrasound-technical considerations and applications in oncologic imaging
D. Clevert, Munich/DE

3. Imaging dissemination pathways in head and neck cancer
M. Mack, Munich/DE

4. Whole body MRI in onology
V. Vandecaveye, Leuven/BE
5. Imaging of lung cancer: implications on management 
L. Bonomo, Rome/IT

6. Imaging of biliary tract tumours
R. Manfredi, Verona/IT

7. Staging of ovarian cancer - providing a GPS to patient management
H. Hricak, New York/US

8. Role of MRI in the diagnosis and management of prostate cancer
H. Vargas, New York/US
9. Tailoring breast imaging surveillance to the woman´s risk
F. Gilbert, Cambridge/UK

10. Imaging of bone tumours
G. Guglielmi, Foggia/IT

11. RECIST, CHOI and beyond
M. D'Anastasi, Munich/DE

Past Webinars 2015

1. DW in Oncologic Imaging
D. M.J. Lambregts, Maastricht/NL
2. CT Colonography
A. Laghi, Latina/IT
3. Cystic and solid pancreatic tumors
G. Zamboni, Verona/IT
4. Imaging the prostate - current status and future developments
J. Futterer, Nijmengen/NL
5. Update on Breast MRI
F. Sardanelli, Milan/IT
6. Structured Oncologic Reporting
W. Sommer, Munich/DE